Andrew R. Jordan serves as Executive at IDERA PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Andrew R. Jordan has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 17, 2023 involved exercising options for 402,529 shares valued at $0.
Andrew R. Jordan currently holds 451,890 shares of IDERA PHARMACEUTICALS, INC. (IDRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew R. Jordan has been a net neutral trader of IDRA stock. They have purchased $0 and sold $0 worth of shares.
Andrew R. Jordan's most recent insider trade was on Jan 17, 2023, when they sold 402,529 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 6, 2023 | IDRA | $52.5K | Payment | 73,940 | $0.71 | Discretionary |
| Sep 28, 2022 | IDRA | $0 | Award | 651,364 | $N/A | Discretionary |